Aspire BioPharma
Quarterly Financials
| Values in thousands | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
Revenue | $63 | $28 | $4 | $1 |
Gross Profit | 12 | 5 | -1 | |
EBITDA | -2,448 | -62 | 4,148 | 1,650 |
EBIT | -1,646 | -1,849 | -370 | |
Net Income | -1,268 | -3,222 | -4,707 | -1,850 |
Net Change In Cash | 63 | 28 | 4 | 1 |
Free Cash Flow | -2,115 | -3,038 | -927 | -1,103 |
Cash | 12,167 | 5,857 | 1,003 | 1,948 |
Basic Shares | 1,037 | 1,494 | 1,494 | 1,238 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $6 | $0 | $0 | $0 |
Gross Profit | 0 | 0 | 0 | |
EBITDA | -11,331 | -11,645 | 5,804 | 3,340 |
EBIT | -19,351 | -1,210 | 4,464 | -596 |
Net Income | -24,480 | -12,537 | 4,464 | 3,340 |
Net Change In Cash | 6 | 0 | 0 | 0 |
Free Cash Flow | -4,923 | -265 | -653 | -5,038 |
Cash | 1,003 | 3 | 11 | 497 |
Basic Shares | 1,494 | 689 | 479 | 898 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-06-30 | $1 |
2026-03-31 | -$20.56 |
2025-12-31 | -$39.97 |
2025-09-30 | -$44.83 |